The “Net Innovation Trend” and What It Means for Big Pharmas, Biotechs, and Generics
By Mark P. Mathieu
Innovation is the key value driver in healthcare. Over the past 8 years, the pharmaceuticals sector has lost a stunning $593 billion (-65%) in market cap while the two sectors with innovation – biotech and med tech – have each added $71 billion (+46%) and $19 billion (+6%) in market cap, respectively. Read More
|
|
IBM Introduces Power7 Family
TODAY
|
Forbes | The Oracle-Sun vs. IBM war is heating up. IBM is announcing its first Power7 servers, Unix machines that will integrate new chips and software.
more
Counting Down to Bio-IT World Expo 2010
TODAY
|
Bio-IT World Expo | We are less than three months away from the kick off to the 2010 Bio-IT World Expo in Boston, being held from April 20-22. All signs point to a brilliant event, with registrations pouring in and exhibitors scrambling for the final few booths. We hope you’ll consider joining us.
more
More Big Pharma Research Cuts
Feb 08
|
Reuters | AstraZeneca, GlaxoSmithKline, and Pfizer all made cuts to R&D budgets and teams last week in an effort to trim research efforts that aren't delivering. But that's still not a proven antidote for what ails Big Pharma.
more
MORE NEWS BELOW
U.S. Scientists Given Access to Cloud Computing by Microsoft
Feb 05
|
New York Times | Microsoft and the National Science Foundation have agreed to offer American scientific researchers free access to the company’s new cloud computing service. A goal of the three-year project is to give scientists the computing power to cope with exploding amounts of research data.
more
Crowdsourcing Diabetes
Feb 05
|
Wired | The Harvard Clinical and Translational Science Center and InnoCentive are launching a series of Web-based innovation challenges aimed at harnessing Web 2.0 and crowdsourcing for the academic public healthcare community.
more
 | StorNext 4.0: Technical Product Brief
Proven in the world’s most data intensive industries, Quantum StorNext is a scalable, high-performance file system which allows data sharing across Linux, Mac, Unix, and Windows operating systems and manages data in enterprise storage environments. In this Technical Brief you'll learn: - How a high-performing file system can accelerate your business
- How to simplify your data management
- How a tiered storage approach can save you money
|  | Protect Your Scientific Intellectual Property: Proof of Lab Informatics Data Authenticity is Your Best Legal Defense As a bio-technology or life sciences organization, your formulas, treatments and research and discoveries are the “lifeblood” of your business. But if you aren't protecting the integrity of your scientific data in your lab informatics systems, you risk losing IP ownership, revenue and consequently your business if you can't prove time-of-creation and data authenticity. Learn how you can implement simple, cost-effective and automated controls to protect your scientific intellectual property. Consider: IP protection requirements in bio-pharma and other science-oriented industries can extend out 20, 30, 40 or more years Most electronic lab management solutions include generic authenticity controls, so how "legally defensible" is yours? Only standards-compliant, independent controls can future-proof your approach to long-term IP integrity protection and authenticity. Learn more - get the free whitepaper now
|  | The Key to Life Sciences Data Management: Transparent Migration Life sciences organizations face new data management challenges as the volume of research data grows and more data is kept online for longer times. Read this paper to learn about: - The benefits of transparent data migration (TDM)
- How TDM technologies can simplify data management.
- How using TDM can help increase storage utilization, improve computational workflow performance, and optimize the use of storage resources.
|
 Next-Generation Clinical Trial and Data Management Applications
Sponsored by Adobe
This webinar introduces i3Cube - a web-based, fully integrated, clinical trial and data management system built on Adobe’s LiveCycle® Enterprise Suite. I3 cube provides end-to-end automation that delivers unprecedented visibility into information that sponsors need to accelerate the study process and complete trials efficiently. Viewers will learn more about:
Creating faster and more efficient trial processes Reducing investigator burden Real-time sponsor transparency into study information Enterprise solutions based on Adobe LiveCycle® ES utilizing cross-platform clients of Reader, Flash and AIR Download now.
 |
Innovative management in clinical trials
|
 |
Leaders in quality training resources
|
 |
Reports evaluating issues in pharmaceutical technology, business, and therapeutic markets
|
|
|
Feb 8, 2010
| Bio-IT World |
FULL STORIES
- Therapeutic Tax Credit to help small biotechs pay for research?
- AB SCIEX launches new company dedicated to life science analytical technologies
- Finland invests in European biomedical research infrastructures
- Infosys Technologies will design and implement the Research Informatics System at Elan Pharmaceuticals
- IBM has signed an agreement to acquire Initiate Systems
- GSK purchases lung disease drug from Apeiron Biologics
- Teva buts heads with Amgen
- RainDance Technologies appoints Sirshendu Roopom Banerjee as President and CEO
Bio-IT Weekly Update
eCliniqua
Pharma Services News
Employers -- Don't miss this opportunity to reach well-qualified life science candidates.
|